These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20891009)

  • 21. Phospholipid-based Immobilized Artificial Membrane (IAM) Chromatography: A Powerful Tool to Model Drug Distribution Processes.
    Sobanska AW; Brzezinska E
    Curr Pharm Des; 2017; 23(44):6784-6794. PubMed ID: 29046146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of V(ss) from in vitro tissue-binding studies.
    Berry LM; Roberts J; Be X; Zhao Z; Lin MH
    Drug Metab Dispos; 2010 Jan; 38(1):115-21. PubMed ID: 19797608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
    Longhi R; Corbioli S; Fontana S; Vinco F; Braggio S; Helmdach L; Schiller J; Boriss H
    Drug Metab Dispos; 2011 Feb; 39(2):312-21. PubMed ID: 21071520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
    Fridén M; Bergström F; Wan H; Rehngren M; Ahlin G; Hammarlund-Udenaes M; Bredberg U
    Drug Metab Dispos; 2011 Mar; 39(3):353-62. PubMed ID: 21149540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the calculation of the concentration dependence of drug binding to plasma proteins with multiple binding sites of different affinities: determination of the possible variation of the unbound drug fraction and calculation of the number of binding sites of the protein.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Feb; 96(2):249-57. PubMed ID: 17051587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the interactions of multicomponents in Cornus officinalis Sieb. et Zucc. with human serum albumin using on-line dialysis coupled with HPLC.
    Liu X; Han ZP; Wang YL; Gao Y; Zhang ZQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(9-10):599-604. PubMed ID: 21345748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capillary electrochromatography as a new tool to assess drug affinity for membrane phospholipids.
    Barbato F; Grumetto L; Carpentiero C; Rocco A; Fanali S
    J Pharm Biomed Anal; 2011 Apr; 54(5):893-9. PubMed ID: 21168987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism.
    Ascoli GA; Domenici E; Bertucci C
    Chirality; 2006 Sep; 18(9):667-79. PubMed ID: 16823814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ANN-QSAR model of drug-binding to human serum albumin.
    Deeb O; Hemmateenejad B
    Chem Biol Drug Des; 2007 Jul; 70(1):19-29. PubMed ID: 17630991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of binding to albumin and alpha 1-acid glycoprotein on the clearance of drugs by the liver.
    Meijer DK; Van der Sluijs P
    Pharm Weekbl Sci; 1987 Apr; 9(2):65-74. PubMed ID: 3295762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico prediction of human serum albumin binding for drug leads.
    Vallianatou T; Lambrinidis G; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2013 May; 8(5):583-95. PubMed ID: 23461733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods.
    Poulin P; Theil FP
    J Pharm Sci; 2009 Dec; 98(12):4941-61. PubMed ID: 19455625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Lombardo F; Obach RS; Shalaeva MY; Gao F
    J Med Chem; 2004 Feb; 47(5):1242-50. PubMed ID: 14971904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsome composition-based model as a mechanistic tool to predict nonspecific binding of drugs in liver microsomes.
    Poulin P; Haddad S
    J Pharm Sci; 2011 Oct; 100(10):4501-17. PubMed ID: 21574165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.
    He J; Shibukawa A; Tokunaga S; Nakagawa T
    J Pharm Sci; 1997 Jan; 86(1):120-5. PubMed ID: 9002471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of human pharmacokinetics--evaluation of methods for prediction of volume of distribution.
    Fagerholm U
    J Pharm Pharmacol; 2007 Sep; 59(9):1181-90. PubMed ID: 17883888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of induced hypoalbuminemia on distribution, total clearance and unbound clearance of piroxicam in vivo in the rat.
    Troconiz JI; Lopez-Bustamante LG; Fos D
    Eur J Drug Metab Pharmacokinet; 1993; 18(2):165-71. PubMed ID: 8243500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.